Qualigen Therapeutics Inc
NASDAQ:QLGN
Qualigen Therapeutics Inc
NASDAQ:QLGN
Price:
0.282 USD
-7.54%
Market Closed
Updated:
May 29, 2024
Qualigen Therapeutics Inc
Net Change in Cash
|
Qualigen Therapeutics Inc
Net Change in Cash Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
Net Change in Cash
-$6.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
-$218m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Qualigen Therapeutics Inc's Net Change in Cash?
Net Change in Cash
-6.6m
USD
-6.6m
USD
Based on the financial report for Dec 31, 2023, Qualigen Therapeutics Inc's Net Change in Cash amounts to -6.6m USD.
What is Qualigen Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
15%
15%
Over the last year, the Net Change in Cash growth was 37%.
You don't have any saved screeners yet
